| (P1103) |
Angiographic Patterns of Drug-Eluting Stent Restenosis and Outcomes after Treatment with Drug-Coated Balloon vs. Balloon Angioplasty |
|
H. Rittger, M. Waliszewski, J. Wöhrle, C. Schlundt, J. Brachmann, C. Garlichs, S. Achenbach (Erlangen, Berlin, Ulm, Coburg) |
| (P1104) |
Paclitaxel-Eluting Balloon vs. Everolimus-Eluting Stent for Treatment of Drug-Eluting Stent Restenosis |
|
M. Almalla, J. Schröder, V. Pross, N. Marx, R. Hoffmann (Aachen) |
| (P1105) |
3 Year Follow up After Treatment of Bare-Metal Stent Restenosis with Second Generation Drug Eluting Stent or First Generation Drug Eluting Stent |
|
M. Almalla, J. Schröder, V. Pross, N. Marx, R. Hoffmann (Aachen) |
| (P1106) |
Role of EuroSCORE II in Predicting Long-Term Outcome after Percutaneous Catheter Intervention for Coronary Triple Vessel Disease or Left Main Stenosis |
|
M. Zhao, S. Stampf, C. M. Valina, R.-P. Kienzle, M. Ferenc, M. Gick, T. Nührenberg, E. Essang, H. J. Büttner, M. Schumacher, F.-J. Neumann (Bad Krozingen, Freiburg im Breisgau) |
| (P1107) |
Influence of completeness of secondary revascularization on long-term mortality in patients with bypass grafting |
|
N. Löffelhardt, H. J. Büttner, G. Leibundgut, F.-J. Neumann (Bad Krozingen) |
| (P1108) |
The Leipzig Prospective Drug-eluting Balloon- Registry: Outcome of 353 Consecutive Patients undergoing Percutaneous Coronary Intervention using Paclitaxel-coated Balloons. |
|
M. Uhlemann, S. Möbius-Winkler, V. Adams, A. Linke, S. Erbs, H. Thiele, G. C. Schuler (Leipzig) |
| (P1109) |
Multi Center, Prospective, Randomized, Single Blind Study of the Elixir DESyneTM Novolimus-Eluting Stent Compared to the Endeavor Stent: 3-Year Results: The EXCELLA II Study |
|
J. Schofer, S. Verheye, C. L. Dubois, K. E. Hauptmann, J. Ormiston, J. Stewart, K. Stangl, B. Witzenbichler, M. Wiemer, E. Barbato, P.-J. Fitzgerald, H. Otake, P. W. Serruys (Hamburg, Trier, Berlin, Minden; Antwerpen, Leuven, Aalst, BE; Auckland, NZ; Calfornia, US; Rotterdam, NL) |
| (P1110) |
Angiographic and clinical outcomes of paclitaxel coated balloon angioplasty versus everolimus coated stent implantation in restenosis of drug eluting stents. |
|
S. Markovic, H. Rittger, M. Waliszewski, C. Garlichs, C. Schlundt, S. Achenbach, J. Wöhrle (Ulm, Erlangen, Berlin) |
| (P1111) |
In-Stent Neoatherosclerosis: Are First Generation Drug Eluting Stents Different Than Bare Metal Stents? An Optical Coherence Tomography Study. |
|
A. Karanasos, M. del Trigo, K. Toutouzas, K. Witberg, J. Ligthart, N. van Mieghem, R.-J. van Geuns, C. Schultz, F. Zijlstra, E. Regar (Rotterdam, NL; Athens, GR) |
| (P1112) |
No indication for an unexpected high rate of coronary artery aneurysms after angioplasty with Drug Coated Balloons. |
|
A. Schulz, K. Bonaventura, F. X. Kleber (Berlin, Potsdam) |
| (P1113) |
Changes in left ventricular function and wall motion determined by cardiac magnetic resonance imaging after successful recanalization of true chronic total occlusion in native coronary arteries |
|
J. Wöhrle, P. Chadid, S. Markovic, W. Rottbauer, P. Bernhardt (Ulm) |
| (P1114) |
Coagulation factor Xa and cardiac catheter thrombosis: results from an in vitro study |
|
A. Kaeberich, U. Raaz, I. K. Reindl, A. Vogt, L. Maegdefessel, B. Hauroeder, M. Buerke, K. Werdan, A. Schlitt (Halle/Saale, Koblenz, Siegen, Quedlinburg; Stanford, US; Stockholm, SE) |